Schedule 13D ownership disclosure

RANI THERAPEUTICS HLDGS INC

Class A Common Stock, par value $0.0001 per share · CUSIP: 753018100

Event date: 2025-10-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • InCube Labs, L.L.C.Reported CIK 0001873082

    Shares: 22,424,788.00 · Class: 18.7%

  • MIR A IMRANReported CIK 0001031686

    Shares: 27,093,552.00 · Class: 22.1%

  • InCube Ventures II, LP

    Shares: 301,710.00 · Class: 0.3%

  • Rani Investment Corp.

    Shares: 7,694.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001873082-25-000003
Form type
SCHEDULE 13D/A
Filer
InCube Labs, L.L.C.
CIK
CIK 1873082
Filed
Oct 27, 2025
Reporting period
Oct 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub